Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

With more than 71 million people chronically infected, hepatitis C virus (HCV) is one of the leading causes of liver disease and hepatocellular carcinoma. While efficient antiviral therapies have entered clinical standard of care, the development of a protective vaccine is still elusive. Recent stud...

Full description

Bibliographic Details
Main Authors: Florian Wrensch, Emilie Crouchet, Gaetan Ligat, Mirjam B. Zeisel, Zhen-Yong Keck, Steven K. H. Foung, Catherine Schuster, Thomas F. Baumert
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Immunology
Subjects:
hepatitis C virus
apolipoproteins
neutralizing antibodies
lipo-viro-particle
viral evasion
ApoE
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01436/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.01436/full

Similar Items